newsfilter
← Latest News
Business Wire·

Virios Therapeutics, Inc. to Present at Investor Summit Group's Q3 Virtual Conference

Virios Therapeutics, Inc. (Nasdaq: VIRI), a development-stage biotechnology company focused on advancing novel, combination antiviral therapies to treat debilitating chronic diseases, including fibromyalgia, today announced that Greg Duncan, Chairman an